Loading...
Chemical structure of Azeliragon

GC19053

Azeliragon

Also known as 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]imidazol-4-yl]phenoxy]-N,N-diethylpropan-1-amine

TTP488 is an antagonist at the Receptor for Advanced Glycation End products, is evaluated as a potential treatment for patients with mild-to-moderate Alzheimer's disease (AD)

ChemicalCAS603148-36-3MW532.12FormulaC32H38ClN3O2
CAS number
603148-36-3
Molecular weight
532.12
Formula
C32H38ClN3O2
Solubility
DMSO ： 50 mg/mL (93·96 mM);Water ： ＜ 0·1 mg/mL (insoluble)
InChIKey
KJNNWYBAOPXVJY-UHFFFAOYSA-N
Catalogue number
GC19053
Brand
GLPBIO
Computed properties PubChem CID 11180124 · XLogP 8.3 · TPSA 39.5 Ų · H-bond donors 0
XLogP
8.3
TPSA
39.5 Ų
H-bond donors
0
H-bond acceptors
4
Rotatable bonds
14
Heavy atoms
38

SMILES CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC

Computed descriptors from PubChem (CID 11180124), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.